Article metrics

Download PDFPDF
Commentary
Comment to: Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study—determination of immunogenicity

 

Online download statistics by month:

Online download statistics by month: March 2024 to June 2024

AbstractFullPdf
Mar 20244382616
Apr 2024118212259
May 20248813613
Jun 202412725823
Total3773242111